Snowball logo
logo
ENZB

EnzymeBioSystems

ENZB • PINK
$0.699-$0.001  (0.14%)
Estimate
EPS
-0.15
Beta
1.166
About the company
Ticker
ENZB
ISIN
Country
United States of America
Sector (GICS)
Materials
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Frequently asked questions

What sector does EnzymeBioSystems (ENZB) operate in?

EnzymeBioSystems belongs to the Materials sector and operates in the Diagnostics & Research industry.

What is EnzymeBioSystems (ENZB) current stock price?

As of the latest data, EnzymeBioSystems stock price is $0.70, with a previous close of $0.70. EnzymeBioSystems lost -$0.00 in the last trading session, representing a -0.14% loss.

What is EnzymeBioSystems (ENZB) current market capitalization?

EnzymeBioSystems market cap is approximately 36.59 million.

What is EnzymeBioSystems (ENZB) Earnings Per Share (EPS)?

The trailing EPS is -$0.15.

Does EnzymeBioSystems (ENZB) pay dividends?

No. EnzymeBioSystems does not pay a dividend.

What is EnzymeBioSystems (ENZB) beta (volatility) score?

EnzymeBioSystems has a beta of 1.166, meaning its volatility is roughly in line with the market.